LUS, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 303
AS - Asia 154
EU - Europa 116
AF - Africa 17
Totale 590
Nazione #
US - Stati Uniti d'America 295
IT - Italia 66
SG - Singapore 65
HK - Hong Kong 43
CN - Cina 22
CI - Costa d'Avorio 17
GB - Regno Unito 13
IN - India 13
NL - Olanda 10
VN - Vietnam 9
CA - Canada 8
UA - Ucraina 7
DE - Germania 5
SE - Svezia 5
FI - Finlandia 3
BE - Belgio 2
IR - Iran 2
LT - Lituania 2
RU - Federazione Russa 2
IE - Irlanda 1
Totale 590
Città #
Santa Clara 53
Singapore 52
Hong Kong 43
Chandler 28
Ashburn 25
Naples 13
Dearborn 10
Napoli 9
Beijing 8
Dong Ket 8
Ottawa 8
Boston 7
Lawrence 7
Millbury 7
Amsterdam 6
Norwalk 6
Des Moines 5
Wilmington 5
Princeton 4
Seattle 4
Solofra 4
Atripalda 3
Jacksonville 3
Nanchang 3
Nanjing 3
Atlanta 2
Aversa 2
Cambridge 2
Lappeenranta 2
Milan 2
Redhill 2
Redwood City 2
Rome 2
Washington 2
Woodbridge 2
Ardabil 1
Augusta 1
Bloomsbury 1
Brussels 1
Campo San Martino 1
Cercola 1
Changzhou 1
Dallas 1
Dublin 1
Faenza 1
Fairfield 1
Gurgaon 1
Hebei 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
Jiaxing 1
Kasterlee 1
Kunming 1
Leawood 1
Ningbo 1
Ottaviano 1
Portici 1
Torre del Greco 1
Zhengzhou 1
Totale 369
Nome #
Clinical and 3D instrumental assessment of the short-term effect of Sativex on patients with multiple sclerosis 59
Adiponectin profile at baseline is correlated to progression and severity of Multiple Sclerosis 57
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery 45
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 43
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 41
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis 39
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis 39
Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 39
Prognostic indicators in pediatric clinically isolated syndrome 36
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 33
Migraine as possible red flag of PFO presence in suspected demyelinating disease 32
Signs and symptoms of COVID-19 in patients with multiple sclerosis 26
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 23
MOLECULAR DIAGNOSTICS IN THE CLINICAL PRACTICE" RESEARCH CENTRE CETAC" CASERTA (ITALY) THE 23/24 MAY 2014 21
A real-world study of alemtuzumab in a cohort of Italian patients 20
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response 19
Advancing Healthcare Through AI: Innovations in Monitoring and Diagnostic Technologies at the Augmented Reality for Health Monitoring Laboratory (ARHeMLab) 17
PERSONALIZED MEDICINE IN THE CLINICAL PRACTICE: THE ROLE OF FUNCTIONAL GENOMICS RESEARCH CENTRE CETAC" CASERTA (ITALY) THE 04/05 DECEMBER 2015 16
Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue 10
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 9
Normative values of the brief international cognitive assessment for multiple sclerosis (BICAMS) in an Italian young adolescent population: the influence of age, sex, and education 4
Totale 628
Categoria #
all - tutte 3.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 6 3 2 0 1 3
2020/202169 3 2 1 3 1 4 1 6 9 22 9 8
2021/202277 2 0 0 4 1 4 0 5 1 15 26 19
2022/202392 11 3 1 0 13 13 4 10 20 7 4 6
2023/2024121 6 14 7 10 15 18 2 19 1 4 15 10
2024/2025207 30 22 5 8 40 56 46 0 0 0 0 0
Totale 628